A new study protocol published in BMC Musculoskeletal Disorders outlines the suggested use of Platelet Rich Plasma (PRP) in treating hamstring injuries. While there have been multiple studies promoting the benefits of PRP in soft tissue injuries, this study will be unique in that it will be the first to use a randomized control trial to evaluate the effects of PRP on muscle healing.
28 athletes with grade 2 hamstring injuries will take part. Participants will be split into two groups: one will receive PRP plus a rehabilitative program, and the control group will receive a rehabilitative program only. Participants will be followed weekly for 4 months to assess their ability to return to play.
While we have used PRP in hamstring injuries with very encouraging results, these findings have been mostly anecdotal to date. We look forward to seeing the results of this randomized control trial once it is published!
